The University of Chicago Header Logo

Connection

Jon E. Grant to Drug Administration Schedule

This is a "connection" page, showing publications Jon E. Grant has written about Drug Administration Schedule.
Connection Strength

0.565
  1. N-Acetylcysteine in the Treatment of Excoriation Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2016 May 01; 73(5):490-6.
    View in: PubMed
    Score: 0.119
  2. The effect of self-regulated caffeine use on cognition in young adults. Hum Psychopharmacol. 2015 Mar; 30(2):123-30.
    View in: PubMed
    Score: 0.110
  3. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry. 2008 May; 69(5):783-9.
    View in: PubMed
    Score: 0.068
  4. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry. 2007 Sep 15; 62(6):652-7.
    View in: PubMed
    Score: 0.064
  5. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry. 2006 Feb; 163(2):303-12.
    View in: PubMed
    Score: 0.059
  6. Advances in the pharmacological treatment of pathological gambling. J Gambl Stud. 2003; 19(1):85-109.
    View in: PubMed
    Score: 0.047
  7. An open-label study of naltrexone in the treatment of kleptomania. J Clin Psychiatry. 2002 Apr; 63(4):349-56.
    View in: PubMed
    Score: 0.045
  8. Successful treatment of nondelusional body dysmorphic disorder with olanzapine: a case report. J Clin Psychiatry. 2001 Apr; 62(4):297-8.
    View in: PubMed
    Score: 0.042
  9. Pathological gambling. Current status and new treatments. Minn Med. 2002 Jul; 85(7):48-50, 52.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.